PARP inhibitor monotherapy

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this GU CONNECT programme, brought to you by Dr Neal Shore, you’ll follow a patient through their metastatic castration-resistant prostate cancer (mCRPC) journey and explore the clinical implementation of genetic testing and monotherapy treatment with a PARPi.

Watch the 5-minute animated video and download the accompanying slides for an update on:

- Efficacy and safety profiles of PARP inhibitors for prostate cancer
- The role of genetic testing and how to use it to assess HRRm status and influence treatment decision-making
- Data from key PARPi mCRPC studies and the clinical implication of this data

Visit the COR2ED website to download the free accompanying slide set or to watch more videos like this one: https://cor2ed.com/gu-connect/programmes/parpi-patientjourney-prostatecancer/

This video is supported by an Independent Medical Education Grant from AstraZeneca.

Publication date: JUL 2023
Category
Oncology
Be the first to comment

Up Next